HUBUNGAN PEMAKAIAN KONTRASEPSI HORMONAL DENGAN KEJADIAN KANKER PAYUDARA

Authors

  • Umi Mustikasari Program Studi DIII Kebidanan, Fakultas Ilmu Kesehatan, Universitas Pahlawan Tuanku Tambusai http://orcid.org/0000-0001-7828-1533
  • Sriwidya Astuti Khati Program Studi DIII Kebidanan, Fakultas Ilmu Kesehatan, Universitas Pahlawan Tuanku Tambusai

DOI:

https://doi.org/10.31004/jkt.v3i2.4424

Keywords:

Keywords: Breast cancer, hormonal contraception

Abstract

Breast Cancer is a malignant tumor in the breast or one breast. Based on the data obtained at the Arifin Achmad Regional General Hospital in 2017, the number of breast cancer patients was 2,217 cases and until now it is still ranked first in the 10 biggest diseases in the Arifin Achmad Province Riau Hospital. The purpose of this study is to know the relationship between hormonal contraception and the incidence of cancer in polyclinics and inpatient care at Arifin Achmad Hospital in 2018. The design of this study was case control with a sample of 194 cases and 194 controls. Data were collected in the form of secondary data. Random sample technique Systematic Random Sampling. Data were analyzed bivariate by Chi-Square and multivariate by using Double Logistic Regression test risk factor model. The results of the research showed that there was a relationship between the use of hormonal contraception and the incidence of breast cancer (p-value = 0,000) with OR = 3,824. The conclusion is that women who use hormonal contraception are 3 times more likely to develop breast cancer than women who do not breast cancer. In addition, the risk of using hormonal contraception is controlled by family history, parity, and breastfeeding.  

References

DAFTAR PUSTAKA

(IARC), I. A. (2012). Estimated Cancer Incidence, Mortality and prevalence Worldwide. Retrieved Me.http;//globocan.iarc.fr/ia/world/atlas.html, 2017, from Globocan.

Alteri, R., Barnes, C., Burke, A., Gansler, T., Gapstur, S., Gaudet, M., … Jiaquan. (2014). Breast Cancer Facts & Figures 2013-2014. : American Cancer Society Inc. 250.

Ardiana, Negara, hidayat wijaya, & Sutisna, M. (2013). Analisis Faktor Risiko Reproduksi yang Berhubungan dengan Kejadian Kanker Payudara pada Wanita. Kesehatan, 1, 106–111.

Duarsa, D. P. (2013). Risk factors of breast cancer in women at Sanglah General . Indonesian Journal of Cancer.

Hendri Fitoni. Faktor Risiko Kanker Payudara Di RSUD DR.Soedarso Pontianak. Univ. Diponegoro XXXIII, 81–87 (2012).

Kemenkes RI. (2015). Panduan penatalaksanaan kanker payudara. Acuan Pedoman Praktis Klinis Kanker Payudara, 1–2. Retrieved from kanker.kemkes.go.id/guidelines/PPKPayudara.pdf

Kementerian Kesehatan RI. (2016). Infodatin Pusat Data dan Informasi Kementerian kesehatan RI.

Mulyani, NS & Rinawati, M. (2013) Kanker Payudara dan PMS pada Kehamilan. Nuha Medika. Yogyakarta.

Nissa, putri adinia esca, Widjajanegara, H., & Purbaningsih, W. (2017). Kontrasepsi Hormonal sebagai Faktor Risiko Kanker Payudara di RSUD Al-Ihsan Bandung. Bandung Meeting on Global Medicine & Health (BaMGMH), 1(22), 112–119.

Poosari, A., Promthet, S., Kamsa-ard, S., Suwanrungruang, K., Longkul, J., & Wiangnon, S. (2014). Hormonal Contraceptive Use and Breast Cancer in Thai Women. Journal of Epidemiology, 24(3), 216–220.

Prabandari, F., & Fajarsari, D. (2016). Faktor-Faktor Yang Mempengaruhi Kejadian Kanker Payudara di RSU Dadi Keluarga Purwokerto. Bidan Prada: Jurnal Ilmiah Kebidanan, 7(1), 105–118.

Priyatin, C., Ulfiana, E., & Sumarni, S. (2015). Faktor Risiko yang Berpengaruh terhadap Kejadian Kanker Payudara di RSUP DR. Kariadi Semarang. Jurnal Kebidanan, 2(5), 9–19. Retrieved from http://ejournal.poltekkes-smg.ac.id/ojs/index.php/jurkeb/article/view/102

Sastrosudarmo (2010). Kanker the Silent Killer. Garda Media. Jakarta.

Savitri, A, dkk. (2015). Kupas Tuntas Kanker Payudara, Leher Rahim dan Rahim. Pustaka Baru Press. Yogyakarta.

Setiowati, D. ayu intan, Tanggo, E. herman, & Soebijanto, R. indrawati. (2016). Hubungan antara Pemakaian KB Hormonal dengan Kejadian Kanker Payudara di Poli Onkolog Satu Atap RSUD Dr. Soetomo, Februari-April 2015. Indonesian Journal of Cancer, 10(January-March), 11–17.

Soroush, A., Farshchian, N., Komasi, S., Izadi, N., Amirifard, N., & Shahmohammadi, A. (2016). The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis. Journal of Cancer Prevention, 21(4), 294–301. https://doi.org/10.15430/JCP.2016.21.4.294

Downloads

Published

2022-06-03

How to Cite

Mustikasari, U., & Khati, S. A. (2022). HUBUNGAN PEMAKAIAN KONTRASEPSI HORMONAL DENGAN KEJADIAN KANKER PAYUDARA . Jurnal Kesehatan Tambusai, 3(2), 145–152. https://doi.org/10.31004/jkt.v3i2.4424

Issue

Vol. 3 No. 2 (2022): Juni 2022

Section

Articles

License

Copyright (c) 2022 Umi Mustikasari, Sriwidya Astuti Khati

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).